Molecular Targeting Technologies Competitors and Similar CompaniesClear all

Molecular Targeting Technologies's competitors and similar companies include Cardiff Oncology, GenomeMe, BioInvent and iOnctura.

	Molecular Targeting Technologies Molecular Targeting Technologies is a biotech company developing diagnostic and therapeutic molecules for cancer and cardiovascular diseases.	Cardiff Oncology Cardiff Oncology is a biotech company.	GenomeMe GenomeMe is a company engaged in the manufacturing and distribution of antibodies and in vitro diagnostics.	BioInvent BioInvent focuses on the discovery and development of antibody-based drugs against cancer.	iOnctura iOnctura is a company that develops bio-molecules intended for the treatment of cancer and fibrosis.
Founding Date	Founding Date N/A	Founding Date 1999	Founding Date 2015	Founding Date 1997	Founding Date 2017
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech drug development ecommerce medical diagnostics oncology	Tags Healthcare biotech drug development medical diagnostics oncology	Tags Healthcare biotech drug development medical diagnostics oncology	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare biotech drug development healthtech medical diagnostics oncology
Locations	Locations West Chester, US HQ	Locations San Diego, US HQ	Locations Richmond, CA HQ	Locations Lund, SE HQ	Locations Genève, CH HQ
Employees	Employees 717% increase	Employees 14	Employees 525% increase	Employees 118	Employees 343% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 145.2 m	Valuation ($) N/A	Valuation ($) 285.9 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $593k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) kr226.5m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($45.9m) (FY, 2025)	Net income N/A	Net income (kr332.9m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 50.5m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 22.4m